Recipient Organization
APPLIED BIOTECHNOLOGY INSTITUTE
(N/A)
SAN LUIS OBISPO,CA 93407
Performing Department
(N/A)
Non Technical Summary
Non-Technical SummaryPancreas Disease (PD) is a highly transmissible, viral disease of salmon and rainbow trout caused by the salmonid alphavirus. In farmed salmon PD causes morbidity and mortality, and consequently affects productivity, fish size, and health. In highly stocked aquaculture pens, this disease transmits readily within pens and the virus is also carried by water currents to other aquaculture pens. It has been shown that this virus can remain infective for extended periods.One of the most economical ways to protect livestock is by using immunizations to guard against disease. This approach can be challenging since most vaccines are injected, which presents practical problems for administration to commercial lifestock. This is particularly true with fish vaccines due to the labor required to handle them individually in an aqueous environment and the need to keep the costs low.Oral delivery of subunit vaccines is a promising alternative approach. Recent work using new technology to bioencapsulate the vaccine candidate into maize grain enables the antigen to reach target cells and elicit an efficacious immune response. Our preliminary work has shown this technique can also work for fish vaccines. Successful completion of this work will result in the development of the first commercial subunit oral vaccine for Pancreas Disease. This will set a precedent for vaccines for other pathogens in fish and provide a new tool to combat disease in a labor-saving, cost effective manner.
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Goals / Objectives
Goals / ObjectivesAquaculture is a livestock industry that farms fish for consumption. This growing market is threatened with transmissible diseases that are highly detrimental to growth, but some of these diseases are also transmitted to wild fish. Pancreatic Disease is one such highly transmissible disease that causes morbidity and mortality in farmed salmon. Vaccines are used to protect against disease in aquaculture. However, administration of current vaccines requires individual handling of fish, a difficult and labor-intensive process. We have chosen two antigens, E1 and E2, from the virus for use as antigens. Our goal is to develop an effective orally administered vaccine which can be delivered with feed, ensuring that all fish are protected. Our goals for this project are to1. Optimize the codon sequence for antigens E1 and E2 for expression in maize.2. Design a construct containing both E1 and E2 under the control of an embryo promoter and including a selectable marker.3. Produce three variations of the construct using different intracellular targeting locations: cell wall, endoplasmic reticulum, and vacuole.4. Obtain Agrobacterium transformed with the constructs.5. Transform maize and obtain at least 10 independent transformants for each construct6. Analyze transformants for expression of E1 and E2 using antibodies provided by a commercial partner.7. Analyze antigens from transformants by gel electrophoresis and western blotting to ensure integrity of the antigens.8. Identify and propagate transformants containing the highest level of expression of the antigens.9. Defat maize flour from identified transformants with supercritical fluid extraction (SFE) to stabilize the antigens.10. Formulate the flour for oral delivery to salmon.A secondary goal, conducted using commercial partner funding, is to demonstrate that bioencapsulated E1 and E2 antigens in maize produce a protective immune response in salmon.The primary goal of this project will be accomplished in a 12-month time frame using 1.1 FTE of scientists and technical staff.
Project Methods
MethodsMethods used in this project:1. Molecular biology: Standard molecular biology technology will be used for synthesizing DNA sequences with optimized maize codon usage, construction of plasmids incorporating E1 and E2 antigens under the control of an embryo promoter. Three versions of the constructs will be made, targeting the antigens to different intracellular locations: cell wall, endoplasmic reticulum and vacuole.2. Transformation and propagation of maize: The constructs will be transformed into Agrobacterium. These Agrobacterium will be used to transform maize by standard tri-parental mating, with a target of 10 independent transformation events for each construct. The transformed maize will be selected and grown by standard methods.3. Biochemistry: Maize expression of the antigens will be assessed using standard biochemistry procedures. The levels of antigen will be estimated by using antibodies specific for the antigens in ELISA and western blotting. This will allow both the levels and the integrity of the antigens to be evaluated.4. Processing and formulation: The highest-expressing maize seed will be ground to flour and will be defatted using supercritical fluid extraction (SFE). We have evidence that defatting with SFE stabilizes the antigen and achieves a better mucosal immune response.5. Immunology: The formulation will be fed to salmon in a separate study funded by an outside partner to evaluate immune response and protection.